CO-CREATOR

Dr. Christopher McCabe is a Co-Creator and the Chief Scientific Officer for The ASSESS Project. He is the originator of the Value Engineered Translation framework that underpins much of the service offerings. Dr. McCabe has overall responsibility for product content and quality assurance (QA). Part of his QA portfolio includes the recruitment and accreditation of analysts and experts who undertake service delivery. He also leads the development of new products. Dr. McCabe is the lead for Business Development in the UK and EU markets. Concurrent with his role in The ASSESS Project, Professor McCabe has lead responsibility for Queens University Belfast’s Belfast Region City Deal Programme. Powered by over £170 million of investment from the UK government, the programme will deliver Innovation Centres in Deep Tech, Advanced Manufacturing and the Life Sciences, to create jobs and drive inclusive economic growth across Northern Ireland.  Previously, he was the CEO of the Institute of Health Economics in Alberta, Canada, and Professor of Health Economics at the University of Alberta. He has 30 years experience as a health economist working in the area of economic evaluation and health technology assessment. He has contributed to several standard setting documents related to the evaluation of innovative health technologies both nationally and internationally, including the second edition of the NICE Guide to the Methods of Health Technology Appraisal, the fourth edition of the CADTH Guidelines for the Economic Evaluation of Health Technologies, and third edition of the ISSC Guidelines for the translation of stem cell research and regenerative medicine. He has been an expert witness to both the UK and Canadian House of Commons Health committees and recently advised Canada’s Patented Medicines Price Review Board on the development of Value Based Pricing for patented drugs in Canada.

CO-CREATOR

Dan Palfrey is a Co-Creator and the Chief Partnership Officer for The ASSESS Project. He leads strategic development, partnerships, program development, and oversees the delivery of all business functions. Dan is leading Business Development in North American markets. Previously, he was Director of Industry Partnerships at the Institute of Health Economics, a research institute located in Alberta, Canada. Following completion of a Master of Public Health degree from the University of Alberta, Dan began his career in the pharmaceutical industry, holding progressive leadership positions in Commercial and Government Relations roles. He then served as Vice President, Commercialization, for what became one of Canada’s leading electronic medical record companies. He led the company from early growth to acquisition by one of Canada’s largest corporations. He is Board member of The Health Data Coalition, and past Board Member of the Canadian Association for Population Therapeutics, and an Advisor to a number of organizations in the health innovation ecosystem.

CO-CREATOR

Bryan Grunow is a Co-Creator and the Chief Technology Officer for The ASSESS Project. He is a Distinguished Software Architect and is located in Raleigh, NC. He is 24-year software industry veteran who has worked across the software landscape from low-level software design and development to leading engineering units (development, test, performance engineering, and operations) to design, deploy, and manage next generation cloud platforms. He started his career working for Attachmate (now Micro Focus) a leading enterprise software company. From there he worked for a number of Internet start-ups with one eventually being acquired by BlackBerry.

ADVISOR

Andrew Dillon graduated from the University of Manchester in 1975. He held several senior management positions in the UK National Health Service, including General Manager of the Royal Free Hospital and Chief Executive of St George’s Hospital, both academic health centres in London. He was the founding Chief Executive of NICE, the National Institute for Health and Care Excellence in England from 1999 to 2020. He is now a visiting professor at the Institute of Global Health Innovation, Imperial College, London and works as an independent consultant.

ADVISOR

Dr. Richard Edlin is a Senior Lecturer in Health Economics at the School of Population Health at the University of Auckland.  His research centres around the use and interpretation of preferences in informing health care decision making, although he contributes towards economic evaluations alongside clinical trials and decision analytic modelling.  He is the first author of a textbook on Health Technology Assessment held in 250 libraries worldwide and has a keen interest in the effective communication and dissemination of health economic methodology.  Most of his current applied research is in the area of Women and Children’s Health. Prior to his current role, he has also held previous positions at the Universities of Sheffield and Leeds within the United Kingdom.

ADVISOR

Dr. Paula Lorgelly is Chair, Health Economics at The University of Auckland. Previously, she was Professor of Health Economics in the Department of Applied Health Research at University College London. Paula has over 20 years’ experience working in academia in the United Kingdom, Australia and New Zealand (including a visiting position in Germany) and the independent sector in the United Kingdom. Whilst in Australia she was a member of the Economics Sub-Committee of the Pharmaceutical Benefits Advisory Committee (PBAC), and in this capacity provided advice on the effectiveness and cost-effectiveness of treatments seeking reimbursement on the Pharmaceutical Benefits Scheme. Paula has worked across the health and medical spectrum and much of her clinical research has focused on oncology, particularly genomics and precision medicine. More recently she has begun working in the digital health/digital technology space. Paula is the national organiser of the UK Health Economists’ Study Group, an elected position. She is a member of the EuroQol Group, and on the Editorial Boards of the Journal of Cancer Policy, The Patient and the International Journal of Environmental Research and Public Health.

ADVISOR

Daniel A. Ollendorf, PhD, is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Research Assistant Professor of Medicine at Tufts University School of Medicine. Prior to joining CEVR, he spent ten years as the Chief Scientific Officer at the Institute for Clinical and Economic Review (ICER). Dr. Ollendorf currently serves as a non-resident Fellow at the Center for Global Development, and as Chair of the Health Technology Assessment International (HTAi) Global Policy Forum.